Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Encapsulating Peritoneal Sclerosis

glucose, (beta-d)-isomer has been researched along with Encapsulating Peritoneal Sclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Iguchi, D; Ito, Y; Maruyama, S; Mizuno, M; Okada, A; Okada, H; Sakata, F; Suzuki, Y1
Chaudhary, K; Gupta, S; Khanna, R; Mohan, RR; Moore, H; Tandon, A1
Balzer, MS; Bartosova, M; Haller, H; Nordlohne, J; Rong, S; Schmidt, S; Schmitt, CP; Shushakova, N; Stapel, B; von Vietinghoff, S; Zemtsovski, JD1
Bai, Y; Chen, C; Jiang, H; Li, Y; Lin, R; Shentu, Y; Sun, S; Xie, S; Zhang, Y; Zheng, C; Zhou, Y1

Other Studies

4 other study(ies) available for glucose, (beta-d)-isomer and Encapsulating Peritoneal Sclerosis

ArticleYear
Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.
    American journal of physiology. Renal physiology, 2018, 12-01, Volume: 315, Issue:6

    Topics: Animals; Complement Activation; Complement C5a; Complement Inactivating Agents; Disease Models, Animal; Disease Progression; Male; Peritoneal Fibrosis; Peritoneum; Peritonitis; Pyruvaldehyde; Rats, Sprague-Dawley; Severity of Illness Index; Signal Transduction; Time Factors; Zymosan

2018
Nanotechnology and adeno-associated virus-based decorin gene therapy ameliorates peritoneal fibrosis.
    American journal of physiology. Renal physiology, 2014, Oct-01, Volume: 307, Issue:7

    Topics: Adenoviridae; Animals; Decorin; Gene Transfer Techniques; Genetic Therapy; Nanoparticles; Peritoneal Fibrosis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Zymosan

2014
SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.
    Biomolecules, 2020, 11-19, Volume: 10, Issue:11

    Topics: Adolescent; Animals; Benzhydryl Compounds; Cell Line, Transformed; Cells, Cultured; Dialysis Solutions; Female; Glucose; Glucosides; Humans; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Peritoneum; RAW 264.7 Cells; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ultrafiltration

2020
Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    International immunopharmacology, 2021, Volume: 93

    Topics: Animals; Benzhydryl Compounds; Cells, Cultured; Cytokines; Glucose; Glucosides; Humans; Male; Mice, Inbred C57BL; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Signal Transduction; Smad Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transforming Growth Factor beta1

2021